Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Free Newsletter Sign Up

Democrats Seek GAO Probe of Gilead’s Covid Treatment Remdesivir

July 28, 2020, 3:44 PM

U.S. House Oversight Cmte Chair Carolyn Maloney and Sen. Debbie Stabenow ask the Government Accountability Office to investigate the discovery and development of Gilead’s remdesivir.

  • Gilead announced it will charge govt programs $390 per vial, or $2,340 per five-day treatment of the drug, joint statement says
  • “Because of the high price,” the lawmakers are asking GAO to also examine what legal rights federal agencies have related to their contributions to the discovery and development of remdesivir: statement
  • Link to letter
  • NOTE: Stabenow is top Democrat on Senate Finance Cmte health panel

To contact the reporter on this story:
Kim ...